High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis (HiCy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00939549
Recruitment Status : Suspended (Suspended for revisions to the protocol.)
First Posted : July 15, 2009
Last Update Posted : November 9, 2010
Information provided by:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins